Literature DB >> 6173987

Fine structure of the intercellular space of psoriatic epidermis during retinoid (RO 10-9359) and retinoid-PUVA treatment.

L Kanerva, J Lauharanta, K M Niemi, A Lassus.   

Abstract

The enlarged intercellular space in the lower malpighian layers of untreated psoriasis contains a fine granular and a coarse granular substance. Both types of this substance increase in amount during 2-6 weeks of retinoid (RO 10-9359) therapy. Retinoid stimulates the formation of these substances, which previously have been termed "mucus". After glutaraldehyde-osmium tetroxide fixation their mucoid nature cannot be ascertained more specific cytochemical techniques being needed for this. A darker, more homogeneous substance in the upper spinous intercellular spaces increases in amount during retinoid therapy. Large amounts of keratinosome-derived lamellae are observed at the boundary of the stratum intermedium and the stratum corneum. Even after 14 weeks of treatment with retinoid or retinoid plus PUVA, at clinical remission, the histological and electron microscopical pictures still show some psoriatic changes, i.e. enlarged intercellular spaces with fine or coarse granular substance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6173987

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  A semiquantitative light and electron microscopic analysis of histopathologic changes in photochemotherapy-induced freckles.

Authors:  L Kanerva; K M Niemi; J Lauharanta
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

2.  The rhino mouse model: the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones.

Authors:  F Bernerd; J P Ortonne; M Bouclier; A Chatelus; C Hensby
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy.

Authors:  L O Kanerva; E Johansson; K M Niemi; J Lauharanta; O P Salo
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.